Study for rare solid tumors in children and teens
Part of Cancer clinical trials.
This study collects information from children and teens with rare solid tumors to better understand these cancers and support future research. You (or your guardian) can join by giving consent, but it’s mainly for people not already registered in certain ongoing pediatric cancer study databases in Germany.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be diagnosed with a rare solid tumor (a cancer that forms a mass/tumor)
- Be from newborn age up to 18 years (or ask about special referral for young adults)
- You or your legal guardian must receive study information and give written consent
- Your tumor diagnosis should not already be registered in existing GPOH pediatric cancer studies or registries
- You should not already be registered in a prospective treatment trial or another GPOH registry
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people (and sometimes family members) connected to rare solid tumors and collects health information and samples (biospecimens). It helps researchers understand how these cancers develop and builds resources for future research, which may benefit you by contributing to better tailored care for rare cancers.
This study is looking at children and teens with very rare tumors to learn more about these conditions and improve future care. It aims to gather information from patients treated at participating centers.
This trial is creating a registry for very rare solid tumors in people up to age 39. Joining helps doctors learn more about these cancers and may connect you with future research opportunities.
This study collects and studies tissue or bone marrow samples from certain childhood tumors. The goal is to learn what’s going on inside the cancer (using molecular testing) to better understand the disease and how it may respond to treatment.
This study follows children and teens with newly diagnosed certain leukemia (ALL) and certain favorable brain tumors to learn best care and outcomes. It may help your team compare standard treatments and monitor health over time.
This trial analyzes the tumor environment in children with solid tumors to find better ways to use immune cells for treatment. It may help develop new cell-based therapies tailored to each child's tumor.
Hear when a new Rare Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.